Recently amended NABP Model State Pharmacy Act and Model Rules now available

MOUNT PROSPECT, Ill. — The recently amended NABP Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy are now available to assist the state boards of pharmacy in developing state laws or board rules in their efforts to protect the public health, NABP posted on its website Wednesday. 

 

The Model Act was revised to add clarifying information on resident and nonresident pharmacy licensure standards and pharmacy inspections, and to recommend that boards should be provided with a report of any inspection of their licensees. 

 

In recognition of the fact that many pharmacy benefit managers design the clinical programs for their associated mail-order and/or network pharmacies, direction and design of clinical pharmacies was added to the list of activities that may constitute the practice of pharmacy by PBMs. 

 

Language also was revised to address 5% rules to avoid conflict with Drug Enforcement Administration controlled substance regulations. The Committee on Law Enforcement/Legislation noted that previous Model Act language limited the amount of product that a pharmacy can transfer to another pharmacy to 5% of its total sales volume. DEA regulations limit the transfer of controlled substances between DEA registrants to 5% of dosage units dispensed. Accordingly, the Model Act reliant on sales volume was amended stating, "providing that such transfers are compliant with federal law."

 

A full summary of the changes can be found in the September 2014 issue of the NABP Newsletter. 

 

The Model Act is available for download from the members section of the NABP website.